Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Transmedics Group Inc (TMDX)

Transmedics Group Inc (TMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Transmedics Group Inc 200 MINUTEMAN ROAD ANDOVER MA 01810 USA

www.transmedics.com Employees: 584 P: 978-552-0900 F: 978-552-0978

Description:

TransMedics Inc. is a commercial-stage medical technology company. It is engaged in transforming organ transplant therapy for end-stage organ failure patients. The company offers Organ Care System, an integrated, compact, portable preservation technology which addresses unmet need for organs for transplantation. TransMedics Inc. is headquartered in Andover, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 2,662,809
Enterprise Value, $K 2,327,059
Shares Outstanding, K 33,562
Annual Sales, $ 241,620 K
Annual Net Income, $ -25,030 K
Last Quarter Sales, $ 108,760 K
Last Quarter Net Income, $ 4,220 K
EBIT, $ 31,450 K
EBITDA, $ 39,630 K
60-Month Beta 2.08
% of Insider Shareholders 7.00%
% of Institutional Shareholders 99.67%
Float, K 31,213
% Float 93.00%
Short Volume Ratio 0.40

Growth:

1-Year Return 10.28%
3-Year Return 247.06%
5-Year Return 305.55%
5-Year Revenue Growth 1,755.76%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.12 on 10/28/24
Next Earnings Date N/A
Earnings Per Share ttm 0.94
EPS Growth vs. Prev Qtr -65.71%
EPS Growth vs. Prev Year 200.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

TMDX Ratios

Ratio
Price/Earnings ttm 82.13
Price/Earnings forward 76.98
Price/Earnings to Growth N/A
Return-on-Equity % 18.74%
Return-on-Assets % 4.39%
Profit Margin % -10.36%
Debt/Equity 0.28
Price/Sales 10.72
Price/Cash Flow 542.37
Price/Book 12.34
Book Value/Share 6.26
Interest Coverage -1.47
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar